Estimates Revisions ResMed, Inc. Deutsche Boerse AG
Stocks
RME
US7611521078
Advanced Medical Equipment & Technology
|
Market Closed -
Deutsche Boerse AG
14:41:56 01/09/2026 BST
|
After hours 21:00:01 | |||
| 204.70 EUR | +0.89% |
|
199.72 | -2.43% |
| 08-31 | KeyBanc Adjusts Price Target on ResMed to $267 From $255, Keeps Overweight Rating | MT |
| 08-19 | Rothschild & Co Redburn Initiates ResMed at Neutral With $230 Price Target | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- RMD Stock
- RME Stock
- Consensus ResMed, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
